Rechallenge of afatinib for EGFR mutated non-small cell lung cancer previously treated with osimertinib - Trial UMIN000049225
Access comprehensive clinical trial information for UMIN000049225 through Pure Global AI's free database. This phase not specified trial is sponsored by Shinshu University School of Medicine and is currently Enrolling by invitation. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000049225
Enrolling by invitation
drug
Trial Details
University Hospital Medical Information Network • UMIN000049225
Rechallenge of afatinib for EGFR mutated non-small cell lung cancer previously treated with osimertinib
Study Focus
Sponsor & Location
Shinshu University School of Medicine
Japan
Timeline & Enrollment
N/A
Oct 18, 2022
N/A
ICD-10 Classifications
Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Middle lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung
Data Source
University Hospital Medical Information Network
UMIN000049225
Non-Device Trial